Publication | Closed Access

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Breast OncologyBrain MetastasesMedicineCancer ManagementPharmacologyPathologyBreast CancerCancer TreatmentOncologyRadiation OncologySingle-group Phase 2